Universität zu Köln

Al-Batran, Salah-Eddin, Goetze, Thorsten O., Mueller, Daniel W., Vogel, Arndt, Winkler, Michael, Lorenzen, Sylvie, Novotny, Alexander, Pauligk, Claudia, Homann, Nils, Jungbluth, Thomas, Reissfelder, Christoph ORCID: 0000-0003-4591-1046, Caca, Karel, Retter, Steffen, Horndasch, Eva, Gumpp, Julia, Bolling, Claus, Fuchs, Karl-Hermann, Blau, Wolfgang, Padberg, Winfried, Pohl, Michael, Wunsch, Andreas, Michl, Patrick, Mannes, Frank, Schwarzbach, Matthias, Schmalenberg, Harald, Hohaus, Michael, Scholz, Christian, Benckert, Christoph, Knorrenschild, Jorge Riera, Kanngiesser, Veit, Zander, Thomas, Alakus, Hakan, Hofheinz, Ralf-Dieter, Roedel, Claus, Shah, Manish A., Sasako, Mitsuru, Lorenz, Dietmar, Izbicki, Jakob, Bechstein, Wolf O., Lang, Hauke and Moenig, Stefan P. (2017). The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI. BMC Cancer, 17. LONDON: BIOMED CENTRAL LTD. ISSN 1471-2407

Schmalenberg, Harald, Al-Batran, Salah-Eddin, Pauligk, Claudia, Zander, Thomas, Reichart, Alexander, Lindig, Udo, Kleiss, Mathias, Mueller, Lothar, Bolling, Claus, Seufferlein, Thomas, Reichardt, Peter, Kullmann, Frank, Eschenburg, Henning, Schmittel, Alexander, Egger, Matthias, Block, Andreas and Goetze, Thorsten Oliver (2018). CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach. J. Cancer Res. Clin. Oncol., 144 (3). S. 559 - 570. NEW YORK: SPRINGER. ISSN 1432-1335

Schmalenberg, Harald, Pauligk, Claudia, Zander, Thomas, Reichart, Alexander, Lindig, Udo, Kleiss, Mathias, Mueller, Lothar, Bolling, Claus, Seufferlein, Thomas, Reichardt, Peter, Kullmann, Frank, Eschenburg, Henning, Schmittel, Alexander, Egger, Matthias, Block, Andreas, Al-Batran, Salah-Eddin and Goetze, Thorsten Oliver (2017). A multicentre, phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the oesophagogastric junction and stomach (CABAGAST). J. Clin. Oncol., 35. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755